Alnylam Offering Value-Based Deals In EU For Breakthrough RNAi Drug Onpattro

 
• By Sten Stovall
Value-Cost
Alnylam offering value- or outcomes-based Onpattro contracts linked to improvements. • Source: Shutterstock

More from Strategy

More from Business